The FDA Center for Veterinary Medicine will host the Third Annual Animal Drug User Fee Educational Conference on July 7, 2026, from 9:00 a.m. to 1:00 p.m. ET. This public meeting will provide educational sessions for stakeholders interested in the new animal drug approval process and the regulatory framework supporting animal drug development.

The conference will be available both in person at the Harvey W. Wiley Federal Building in College Park, Maryland, and virtually via webcast. Presentation topics will include available regulatory pathways, conditional approval and indexing for Minor Use/Minor Species, expanded conditional approval, regulatory flexibility during a public health emergency, animal biotechnology products, the Veterinary Innovation Program, protocol quality, and best practices. The program will also include a Q&A session with FDA representatives, as time allows.

This event may be of interest to animal health, veterinary medicine, regulatory affairs, clinical development, biotechnology, pharmaceutical, academic, and government stakeholders looking to better understand FDA’s animal drug review process, ADUFA-related performance goals, and evolving regulatory considerations for veterinary product development.